Insights

Gathering insights about Avillion LLP…

Similar companies to Avillion LLP

Accelsiors CRO
$100M$250M

Avillion LLP Tech Stack

Avillion LLP uses 8 technology products and services including RSS, jQuery, Lodash, and more. Explore Avillion LLP's tech stack below.

RSS
Content Management System
jQuery
Javascript Libraries
Lodash
Javascript Libraries
PWA
Miscellaneous
Yoast SEO
Search Engines
HSTS
Security
Google Analytics
Web Analytics
LiteSpeed
Web Servers

Media & News

Avillionllp partners with AstraZeneca plc.
Avillion announces expansion of partnership with AstraZeneca on PT027 and will fund and execute a new Phase 3b study.
May 31, 2022 | avillionls.com
Avillionllp launches anti-IL-17 A/F Nanobody.
Avillion LLP, a drug development company focused on the co-development and financing of pharmaceutical candidates from proof-of-concept through to regulatory approval, announces the successful completion and positive top-line results of its Phase 2 trial of sonelokinab (M1095), an investigational anti-IL-17 A/F Nanobody®, in patients with moderate to severe chronic plaque-type psoriasis.
Sep 10, 2020 | www.prnewswire.com
Avillionllp hired Anders Gersel Pedersen as Non-Executive Director of Bond 2 Development 2 GP on Sep 5th '19.
Avillion LLP, a drug development company focused on the co-development and financing of pharmaceutical candidates from proof-of-concept through to regulatory approval, today announces the appointment of Dr Anders Gersel Pedersen as a Non-Executive Director of Bond 2 Development 2 GP, the General Partner of Bond Avillion 2, the Avillion entity that enters into the co-development agreements with pharma partners.
Sep 05, 2019 | www.biospace.com
Avillionllp hired David Chiswell OBE as Non-Executive Director of Bond 2 Development 2 GP on Mar 14th '19.
Avillion LLP, a drug development company focused on the co-development and financing of pharmaceutical candidates from proof-of-concept through to regulatory approval, today announces the appointment of Dr David Chiswell OBE as a Non-Executive Director of Bond 2 Development 2 GP, the General Partner of Bond Avillion 2, the Avillion entity that enters into the co-development agreements with pharma partners.
Mar 14, 2019 | www.prnewswire.com
Avillionllp recognized as Licencing Deal of the Year and Business Development Team of the Year.
Avillion LLP are nominated for Licencing Deal of the Year and Business Development Team of the Year.
Oct 05, 2018 | avillionllp.com
Merck KGaA partners with Avillionllp.
Merck KGaA is partnering Phase II and Phase III development of its therapeutic anti-interleukin-17 (IL-17) A/F Nanobody® (M1095; ALX-0761) for treating plaque psoriasis, with Avillion, a U.K.-based firm focused on financing and co-developing late-stage drug candidates.
Mar 30, 2017 | www.genengnews.com
Merck partnered with Avillionllp on Mar 1st '17.
Merck has signed a collaboration agreement with the UK’s Avillion under which the latter will develop the German drug giant’s anti IL-17 A/F Nanobody as a treatment for plaque psoriasis.
Mar 29, 2017 | www.pharmatimes.com

Avillion LLP's Email Address Formats

Avillion LLP uses at least 1 format(s):

Avillion LLP Email Formats	Example	Percentage
First@avillionllp.com	John@avillionllp.com	72%
First.Last@avillionllp.com	John.Doe@avillionllp.com	15%
FirstLast@avillionllp.com	JohnDoe@avillionllp.com	11%
FLast@avillionllp.com	JDoe@avillionllp.com	2%

Frequently Asked Questions

Where is Avillion LLP's headquarters located?

Avillion LLP's main headquarters is located at 25 Wilton Road London, England sw1v 1lj United Kingdom. The company has employees across 3 continents, including North AmericaEuropeAsia.

What is Avillion LLP's phone number?

You can contact Avillion LLP's main corporate office by phone at

+44-20-3764-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Avillion LLP's official website and social media links?

Avillion LLP's official website is avillionllp.com and has social profiles on LinkedIn.

What is Avillion LLP's NAICS code?

Avillion LLP's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Avillion LLP have currently?

As of April 2026, Avillion LLP has approximately 25 employees across 3 continents, including North AmericaEuropeAsia. Key team members include Vice President Of Clinical Development: A. D.Non Executive Director: D. C.Senior Global Medical Lead: F. A.. Explore Avillion LLP's employee directory with LeadIQ.

What industry does Avillion LLP belong to?

Avillion LLP operates in the Pharmaceutical Manufacturing industry.

What technology does Avillion LLP use?

Avillion LLP's tech stack includes RSSjQueryLodashPWAYoast SEOHSTSGoogle AnalyticsLiteSpeed.

What is Avillion LLP's email format?

Avillion LLP's email format typically follows the pattern of First@avillionllp.com. Find more Avillion LLP email formats with LeadIQ.

When was Avillion LLP founded?

Avillion LLP was founded in 2013.

Avillion LLP

Q: What is Avillion LLP's official website and social media links?

Avillion LLP's official website is avillionllp.com. Avillion LLP has social profiles on LinkedIn.

Q: How many employees does Avillion LLP have currently?

Avillion LLP has approximately 25 employees.

Q: What technology does Avillion LLP use?

Avillion LLP's tech stack includes Open Graph, Twemoji, X-XSS-Protection, Nginx, Contact Form 7.

Q: What is Avillion LLP's NAICS code?

Avillion LLP's NAICS code is 3254 (Pharmaceutical and Medicine Manufacturing).

Pharmaceutical ManufacturingEngland, United Kingdom11-50 Employees

A drug development company with an innovative model for Clinical Development.

We offer a compelling opportunity to partner late phase therapeutic projects for approval in the EU and US and to accelerate their availability to market.